Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients

NCT02511639 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Metastatic

Interventions

DRUG: Everolimus
DRUG: Aromatase Inhibitors

Sponsor

Istituto Oncologico Veneto IRCCS

Collaborators

[object Object]